ReviewCancers2025

Immune Checkpoint Inhibitors and Antibody-Drug Conjugates in Urothelial Carcinoma: Current Landscape and Future Directions.

Shugo Yajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.